Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05924503 · ClinicalTrials.gov registry record

BRAIN-HEART Ultrasound Study Normative Values for Transcranial Doppler Based Cerebral Blood Flow Assessment

A clinical trial of Mechanical Circulatory Support, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT05924503: Recruiting study of Mechanical Circulatory Support, sponsored by Wake Forest University Health Sciences.

NCT05924503 is a study of Mechanical Circulatory Support that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05924503, a study of Mechanical Circulatory Support, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

There is a dire need to establish normative values for transcranial Doppler(TCD) derived cerebral blood flow parameters for each type of Mechanical circulatory support (MCS) device and explore the relationship between the MCS device's systemic flow dynamics and TCD based cerebral flow(CBF) parameters TCD derived cerebral blood flow parameters can then be investigated as targets used to titrate systemic flow dynamics from MCS. Having target flow rates titrated to patient specific condition using TCD may help avoid both hypoperfusion as well as the possibility of hyperemia reperfusion injury contributing to neurological morbidity. We propose a multicenter study to gather normative data on TCD derived CBF and MCS systemic dynamics for a wide range of patient demographics. Such data collection is only possible with multi-center collaboration given the small volume of patients with MCS patients in each center.

Primary Outcome

Normal mean velocity of the intracranial blood vessels (Middle cerebral artery (MCA), Internal carotid artery (ICA) Posterior Cerebral Arteries (PCA), Anterior Cerebral Artery (ACA), Basilar and Vertebral A )is usually \< 80 cm/s in patients with normal cardiac output. We will explore the range of normal values of intracranial vessel velocity in patients with different degree/ type of MCS devices adjusted to the contribution of LV to blood flow 0-10 L/min

Study Locations (1)

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2024-05-22
Est. Completion 2026-06
Wake Forest University Health Sciences

1,140 total trials

What NCT05924503 shows while recruiting

NCT05924503 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Mechanical Circulatory Support appearing as the primary indexed condition, and to 0 interventions.

NCT05924503 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT05924503 about?

NCT05924503 is a clinical study titled "BRAIN-HEART Ultrasound Study Normative Values for Transcranial Doppler Based Cerebral Blood Flow Assessment". There is a dire need to establish normative values for transcranial Doppler(TCD) derived cerebral blood flow parameters for each type of Mechanical circulatory support (MCS) device and explore the relationship between the MCS device's systemic flow dynamics and TCD based cerebral flow(CBF) parameter...

What is the current status of trial NCT05924503?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2024-05-22. Estimated completion is 2026-06.

What conditions does trial NCT05924503 study?

This clinical trial studies the following conditions: Mechanical Circulatory Support.

Who is sponsoring clinical trial NCT05924503?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05924503 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mechanical Circulatory Support

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05924503, the US trial registry maintained by the National Library of Medicine. NCT05924503 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.